H
Hannah E. Carter
Researcher at Queensland University of Technology
Publications - 47
Citations - 351
Hannah E. Carter is an academic researcher from Queensland University of Technology. The author has contributed to research in topics: Medicine & Cost effectiveness. The author has an hindex of 9, co-authored 31 publications receiving 211 citations. Previous affiliations of Hannah E. Carter include University of Sydney.
Papers
More filters
Journal ArticleDOI
Incidence, duration and cost of futile treatment in end-of-life hospital admissions to three Australian public-sector tertiary hospitals: a retrospective multicentre cohort study.
Hannah E. Carter,Sarah Winch,Adrian G. Barnett,Malcolm Parker,Cindy Gallois,Lindy Willmott,Benjamin P. White,Mary Anne Patton,Letitia Burridge,Gayle Salkield,Eliana Close,Leonie K. Callaway,Nicholas Graves +12 more
TL;DR: The incidence rate and cost of futile treatment in end-of-life admissions varied between hospitals, and the overall impact was substantial in terms of both the bed days and cost incurred.
Journal ArticleDOI
Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups
TL;DR: In this article, a human capital approach was adopted to project the long-term impacts of Australian CVD deaths in 2003 on labour force participation and the present value of lifetime income (PVLI) forgone.
Journal ArticleDOI
The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model.
TL;DR: The productivity costs of premature mortality due to cancer in Australia are significant and provide an economic measure of the cancer burden which may assist decision makers in allocating scare resources amongst competing priorities.
Journal ArticleDOI
A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
Hannah E. Carter,Andrew J. Martin,Deborah Schofield,Gillian M. Duchesne,Annette Haworth,Annette Haworth,Colin Hornby,Mark Sidhom,Michael Jackson +8 more
TL;DR: IMRT was estimated to have a modest long term advantage over 3DCRT in terms of both improved effectiveness and reduced cost, and provides quantitative guidance on the cost effectiveness of IMRT whilst long term trial evidence is awaited.
Journal ArticleDOI
Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis
Nicholas R. Fuller,Hannah E. Carter,Deborah Schofield,Hans Hauner,Susan A. Jebb,Stephen Colagiuri,Ian D. Caterson +6 more
TL;DR: In this paper, a Markov model was developed to calculate the incremental cost-effectiveness ratio (ICER), expressed as the cost per quality adjusted life year (QALY) over the lifetime.